Movatterモバイル変換


[0]ホーム

URL:


Prijeđi na sadržaj
Wikipedija
Pretraga

Ezlopitant

Izvor: Wikipedija
Ezlopitant
Klinički podaci
AHFS/Drugs.comMonografija
Identifikatori
CAS broj147116-64-1
ATC kodnije dodeljen
PubChem[1][2]188927
ChemSpider[3]164166
UNII3L098A8MPY DaY
ChEMBL[4]CHEMBL515966 DaY
Hemijski podaci
FormulaC31H38N2O 
Mol. masa454,646
SMILESeMolekuli &PubHem
InChI
InChI=1S/C31H38N2O/c1-22(2)26-14-15-28(34-3)27(20-26)21-32-30-25-16-18-33(19-17-25)31(30)29(23-10-6-4-7-11-23)24-12-8-5-9-13-24/h4-15,20,22,25,29-32H,16-19,21H2,1-3H3/t30-,31-/m0/s1
Key: XPNMCDYOYIKVGB-CONSDPRKSA-N DaY
Farmakoinformacioni podaci
Trudnoća?
Pravni status

Ezlopitant jeorgansko jedinjenje, koje sadrži 31atomugljenika i imamolekulsku masu od 454,646Da.

Osobine

[uredi |uredi kod]
OsobinaVrednost
Broj akceptora vodonika3
Broj donora vodonika1
Broj rotacionih veza8
Particioni koeficijent[5] (ALogP)6,4
Rastvorljivost[6] (logS, log(mol/L))-8,5
Polarna površina[7] (PSA,Å2)24,5

Reference

[uredi |uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  6. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573. 
  7. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286. 

Literatura

[uredi |uredi kod]

Vanjske veze

[uredi |uredi kod]
Portal Medicina
Portal Hemija
Ezlopitant naWikimedijinoj ostavi
5-HT3 Antagonisti
CB1Agonisti (Kanabinoidi)
D2/D3 Antagonisti
H1 Antagonisti (Antihistamini)
mAChAntagonisti (Antiholini)
NK1 Antagonisti
Drugi
Izvor:https://sh.wikipedia.org/w/index.php?title=Ezlopitant&oldid=42271799
Kategorije:
Sakrivena kategorija:

[8]ページ先頭

©2009-2025 Movatter.jp